Is MTNB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MTNB. It does not provide personalized investment advice.

MTNB (Matinas BioPharma Holdings, Inc.) Stock Analysis - Financials

Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded Healthcare sector company. As of September 4, 2026, MTNB trades at $0.19 with a market cap of $2.66M and a P/E ratio of -0.09. MTNB moved +2.43% today. Year to date, MTNB is -71.65%; over the trailing twelve months it is -89.42%. Its 52-week range spans $0.17 to $3.09. Rallies surfaces MTNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are MTNB's key financials?

MTNB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MTNB recently traded at $0.19. Market cap is $2.66M. P/E ratio is -0.09. Revenue is $0.

MTNB Key Metrics

Key financial metrics for MTNB
Metric	Value
Price	$0.19
Market Cap	$2.66M
P/E Ratio	-0.09
EPS	$-2.00
Dividend Yield	0.00%
52-Week High	$3.09
52-Week Low	$0.17
Volume	585.09K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-10.35M
Gross Margin	0.00%

MTNB Analyst Consensus

MTNB analyst coverage data. Average price target: $0.00.

Common questions about MTNB

What are MTNB's key financials?: MTNB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MTNB recently traded at $0.19. Market cap is $2.66M. P/E ratio is -0.09. Revenue is $0.
Is MTNB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MTNB. It does not provide personalized investment advice.